Amgen Inc. News
Bristol Myers Squibb Shakes Up Key Biotech Battleground
The FDA approval of Sotyktu for psoriasis has both ignited and dampened prospects for smaller biotech stocks.
Bristol Myers Squibb Stock: Here's the Key Breakout Level to Watch
Bristol Myers Squibb received good news from the FDA, but only enough to put a key resistance level in play. Here's the level it needs to clear.
Stock Market Today - 9/12: Stocks End Higher Amid Dollar Retreat With Inflation Data In Focus
Stocks finished higher after snapping a three-week losing streak as the dollar continues to slide against its global currency peers.
Bristol Myers Stock Surges After FDA Approves New Plaque Psoriasis Treatment; Amgen Slides
“We believe Sotyktu is a breakthrough in the treatment of patients suffering from moderate-to-severe plaque psoriasis," said Bristol Myers' chief medical officer Samit Hirawat.
Biosimilars Are Saving America $1 Billion Per Month
Competitive drug prices are great for consumers. Turns out, they're good for industry, too.
Stock Market Today – 8/3: Stocks End Higher as Investors Await Key Economic Data
U.S. stocks finished the session higher, reversing two consecutive days of losses, as investors looked past Pelosi's Taiwan visit and ahead to key economic data.
Stock Market Today – 8/2: Stocks Close Lower as Pelosi Visit to Taiwan Spurs Risk-Off Bets
Stocks close lower as House Speaker Nancy Pelosi's landing in Taiwan stokes geopolitical concern.
Stock Market Today – 8/1: Stocks Close Lower as Q2 Earnings Roll On
Investors await second-quarter earnings results from Pinterest, Activision Blizzard, Starbucks, Caterpillar and more for more signs of whether the Fed’s inflation battle is working.
Biogen Stock Clings to Key Level After Explosive Rally
Biogen stock is up almost 40% on Wednesday but is barely holding above a key level. Let's look at the chart.
Americans Heavily Favor Hiring Ex-Cons for Open Jobs
Fully 89% of Americans say ex-offenders should be given a second chance, a survey says.
LeBron James Buying a Piece of a Major League Team
Participation in this sport grew the fastest of any in the U.S. from 2019-21, reaching the 4.8 million-player mark.
DocuSign Stock Jumps On Job Cut Plan Ahead Of New CEO Allan Thygesen
DocuSign said the job cuts will "improve operating margin and support the company’s growth, scale and profitability objectives".